| 000 | 01764 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518033554.0 | ||
| 264 | 0 | _c20191218 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000007475 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Bruijn, Marienke A A M | |
| 245 | 0 | 0 |
_aEvaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA _h[electronic resource] |
| 260 |
_bNeurology _c05 2019 |
||
| 300 |
_ae2185-e2196 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-N-Methyl-D-Aspartate Receptor Encephalitis _xcomplications |
| 650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aEncephalitis _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, GABA _ximmunology |
| 650 | 0 | 4 |
_aSeizures _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _avan Sonderen, Agnes | |
| 700 | 1 | _avan Coevorden-Hameete, Marleen H | |
| 700 | 1 | _aBastiaansen, Anna E M | |
| 700 | 1 | _aSchreurs, Marco W J | |
| 700 | 1 | _aRouhl, Rob P W | |
| 700 | 1 | _avan Donselaar, Cees A | |
| 700 | 1 | _aMajoie, Marian H J M | |
| 700 | 1 | _aNeuteboom, Rinze F | |
| 700 | 1 | _aSillevis Smitt, Peter A E | |
| 700 | 1 | _aThijs, Roland D | |
| 700 | 1 | _aTitulaer, Maarten J | |
| 773 | 0 |
_tNeurology _gvol. 92 _gno. 19 _gp. e2185-e2196 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000007475 _zAvailable from publisher's website |
| 999 |
_c29583575 _d29583575 |
||